Find a Provider | Print Page | Contact Us | Report Abuse | Sign In | Register
Corporate Council Members
Share |

Corporate Council Members Support and Advance AIPM's Mission

The Academy of Integrative Pain Management greatly values its relationships with the commercial sponsors who make the products that enable members to provide the best pain care possible. These sponsors support the goals and mission of AIPM and its programs through a variety of means, including joining the AIPM’s Corporate Council Program.

Many benefits of Corporate Council participation are the same across all levels, while others increase in value as the level of corporate support increases. AIPM welcomes all commercial supporters. Learn more about joining this program here.


Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at and



Depomed, Inc. is a leading specialty pharmaceutical company focused on developing and commercializing products for pain and neurology-related disorders. Founded in 1995, Depomed has built a strong market presence with a highly differentiated portfolio of six marketed products in the areas of mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain.



KemPharm is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs that are designed to be improved versions of widely prescribed, approved drugs. We employ our Ligand Activated Therapy (LAT) platform technology to create new molecular entity (NME) prodrugs in order to improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety. KemPharm has employed its LAT prodrug platform to create a diverse pipeline of prodrug therapeutics that target large market opportunities in pain, attention deficit hyperactivity disorder (ADHD) and other central nervous system indications.


Pernix Therapeutics

Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and pain management. The Company promotes its branded products to physicians through its two sales forces and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.


Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. headquartered in Basking Ridge, New Jersey, is the U.S. subsidiary of Daiichi Sankyo, Co., Ltd. The Company is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs. We currently market therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome, thrombotic disorders, stroke risk reduction, opioid-induced constipation, IV iron therapy and metastatic melanoma.



Kaléo is a pharmaceutical company dedicated to building innovative solutions for serious and life-threatening medical conditions. Our mission is to provide innovative solutions that empower patients to confidently take control of their medical conditions. We believe patients and caregivers are the experts on how their medical condition impacts their lives and are an integral part of our product development process. Kaléo is a privately-held company headquartered in Richmond, Virginia.


Sierra Tucson

For more than 34 years, Sierra Tucson's longstanding legacy of clinical excellence and compassionate care has resulted in recovery for those struggling with substance use disorder, trauma-related issues, disordered eating, chronic pain, mood and anxiety disorders, and co-occurring disorders. A team of professionals utilizes the Sierra Tucson Model®, a holistic approach that ensures accurate diagnosis and individualized treatment. Sierra Tucson combines integrative and experiential therapies with evidence-based practices to provide a full range of treatment methods. Residents receive the resources, support, and tools necessary for long-term change, including one year of Connect365 and a lifetime of alumni services. Sierra Tucson was the co-recipient of the 2017 Clinical Excellence Award by Acadia Healthcare. Call 800-842-4487 or visit